Reuters logo
Germany's Fresenius weighing bid for generic drugmaker Akorn -Bbg
2017年4月7日 / 晚上6点50分 / 7 个月前

Germany's Fresenius weighing bid for generic drugmaker Akorn -Bbg

April 7 (Reuters) - German healthcare group Fresenius SE & Co KGaA is weighing a bid for generic drugmaker Akorn Inc, Bloomberg reported on Friday, citing people familiar with the matter.

The companies are in discussions, though no final decisions have been made, Bloomberg reported.

Akorn’s shares rose as much as 21.5 percent to $30.64 in afternoon trading. The company has a market value of about $3.7 billion.

Fresenius and Akorn were not immediately available for comments. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Anil D‘Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below